Published in J Clin Invest on April 01, 1982
An IgG subclass imbalance in connective tissue disease. Ann Rheum Dis (1988) 0.90
Studies of the pathogenesis of angioimmunoblastic lymphadenopathy. J Clin Invest (1985) 0.80
Autoimmunity to a 28-30 kD cell membrane DNA binding protein: occurrence in selected sera from patients with SLE and mixed connective tissue disease (MCTD). Clin Exp Immunol (1991) 0.79
Association of bacterial carbohydrate-specific cold agglutinin antibody production with immunization by group C, group B type III, and Streptococcus pneumoniae type XIV streptococcal vaccines. Infect Immun (1983) 0.78
New lymphokines produced by SLE sera stimulated lymphocytes: the PNAF (polymorphonuclear activating factors). Clin Exp Immunol (1985) 0.75
T cell control of antibody production. Contemp Top Immunobiol (1974) 8.38
Surface antigenic markers for distinguishing T and B lymphocytes in mice. Transplant Rev (1971) 6.38
Separation of mouse thymocytes into two subpopulations by the use of peanut agglutinin. Cell Immunol (1976) 3.38
Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol (1978) 3.07
Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum (1975) 2.65
Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus. Arthritis Rheum (1973) 2.40
Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells. Arthritis Rheum (1979) 2.28
Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions. J Exp Med (1973) 2.11
Induction of suppressor T cells in systemic lupus erythematosus by thymosin and cultured thymic epithelium. Science (1977) 2.04
Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction. J Clin Invest (1978) 1.93
Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells. J Clin Invest (1979) 1.87
Interaction of peanut agglutinin with normal human lymphocytes and with leukemic cells. Proc Natl Acad Sci U S A (1979) 1.74
Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction. J Clin Invest (1979) 1.49
Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus. J Clin Invest (1976) 1.41
A serum inhibitor of immune regulation in patients with systemic lupus erythematosus. J Clin Invest (1978) 1.27
Nature of T cell-macrophage interaction in helper cell induction in vitro. I. Evidence for genetic restriction of T cell-macrophage interactions prior to T cell priming. Eur J Immunol (1978) 1.10
Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets. J Clin Invest (1979) 1.09
Activation of a human T cell subpopulation bearing receptors for autologous erythrocytes by concanavalin A. J Immunol (1978) 1.06
Separation of concanavalin A-induced human suppressor and helper T cells by the autologous erythrocyte rosette technique. J Clin Invest (1981) 1.03
Direct lysis of lymphocytes by complement in patients with systemic lupus erythematosus. Arthritis Rheum (1972) 1.01
Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells. J Clin Invest (1981) 1.00
Characterization of mouse helper and suppressor T cell subsets separated by lectins. J Immunol (1980) 0.99
Studies of immune functions of patients with systemic lupus erythematosus. V. T cell suppressor function and autologous mixed lymphocyte reaction during active and inactive phases of disease. Arthritis Rheum (1980) 0.97
Immunofluorescence studies of anti-T cell antibodies and T cells in systemic lupus erythematosus. Selective loss of brightly staining T cells in active disease. Arthritis Rheum (1979) 0.97
Studies of immune functions of patients with systemic lupus erythematosus. Arthritis Rheum (1979) 0.92
Specificity of natural thymocytotoxic autoantibody developed in New Zealand black mice. J Immunol (1980) 0.92
Induction and separation of mouse helper T cells by lectins. Immunology (1980) 0.82
The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol (1989) 13.32
Preliminary criteria for classification of adult Still's disease. J Rheumatol (1992) 7.53
A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature (1997) 5.55
Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A (1984) 5.15
Regulation of cell-cell adhesion by rac and rho small G proteins in MDCK cells. J Cell Biol (1997) 4.27
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med (1986) 4.01
The pathogenesis of autoimmunity in New Zealand black mice. Curr Top Microbiol Immunol (1974) 3.98
X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med (1975) 3.70
Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet (2001) 3.51
Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol (1978) 3.07
Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J Immunol (1991) 3.04
X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect. J Exp Med (1975) 3.03
An infectious molecular clone of a Japanese genotype 1b hepatitis C virus. Hepatology (1999) 3.00
The genetics of the immune response to a synthetic double-stranded RNA in a mutant CBA mouse strain. J Immunol (1973) 3.00
Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A (1978) 2.94
Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J Immunol (1980) 2.89
Decline in suppressor T cell function with age in female NZB mice. J Immunol (1974) 2.79
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med (2001) 2.77
Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med (1987) 2.71
Xenopus M phase MAP kinase: isolation of its cDNA and activation by MPF. EMBO J (1991) 2.68
Xenopus MAP kinase activator: identification and function as a key intermediate in the phosphorylation cascade. EMBO J (1992) 2.67
Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J (1996) 2.66
Nucleotide sequence and expression of the cloned gene of bacteriophage SP6 RNA polymerase. Nucleic Acids Res (1987) 2.50
Loss with age in NZB-W mice of thymic suppressor cells in the graft-vs-host reaction. J Immunol (1974) 2.45
Human suppressor T cells induced by concanavalin A: suppressor T cells belong to distinctive T cell subclasses. J Immunol (1977) 2.43
Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol (1994) 2.41
Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet (1992) 2.38
Selective loss of suppressor cell function in New Zealand mice induced by NTA. J Immunol (1977) 2.38
Tomosyn: a syntaxin-1-binding protein that forms a novel complex in the neurotransmitter release process. Neuron (1998) 2.36
Functional relevance of cross-modal plasticity in blind humans. Nature (1997) 2.36
Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology (2005) 2.33
The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A (1969) 2.31
The fokI restriction-modification system. I. Organization and nucleotide sequences of the restriction and modification genes. J Biol Chem (1989) 2.28
Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells. Arthritis Rheum (1979) 2.28
Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med (1996) 2.17
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1998) 2.15
DNA-binding assay for detection of anti-DNA antibodies in NZB-NZW F1 mice. J Immunol (1969) 2.13
B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Engl J Med (1978) 2.11
Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest (1980) 2.06
Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature (1985) 2.05
Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med (1981) 2.05
Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum (1977) 2.03
Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int (2001) 1.99
Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol (1989) 1.97
Specificity and suppressor function of human T cells responsive to autologous non-T cells. J Immunol (1979) 1.97
Phosphorylation of cofilin by LIM-kinase is necessary for semaphorin 3A-induced growth cone collapse. Nat Neurosci (2001) 1.96
Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med (1992) 1.90
Protein A from Staphylococcus aureus-a mitogen for human T lymphocytes and B lymphocytes but not L lymphocytes. J Immunol (1978) 1.89
Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res (1997) 1.87
Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells. J Clin Invest (1979) 1.87
Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med (2001) 1.85
Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens. J Immunol (1976) 1.84
Mesial motor areas in self-initiated versus externally triggered movements examined with fMRI: effect of movement type and rate. J Neurophysiol (1999) 1.83
Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1999) 1.82
Multistep control of pituitary organogenesis. Science (1997) 1.82
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet (2001) 1.79
Effect of the Kobe earthquake on stress and glycemic control in patients with diabetes mellitus. Arch Intern Med (1998) 1.75
The cellular and genetic basis of murine lupus. Immunol Rev (1981) 1.75
Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res (1998) 1.74
The clearance and localization of nucleic acids by New Zealand and normal mice. Clin Exp Immunol (1972) 1.74
Newly discovered mycoplasma isolated from patients infected with HIV. Lancet (1991) 1.70
Cyclophosphamide in lupus nephritis: a controlled trial. Ann Intern Med (1971) 1.70
The pathogenesis of autoimmunity in New Zealand mice. 3. Factors influencing the formation of anti-nucleic acid antibodies. Immunology (1971) 1.68
Tertiary structure of destrin and structural similarity between two actin-regulating protein families. Cell (1996) 1.68
Hematologic aspects of systemic lupus erythematosus. Current concepts. Ann Intern Med (1977) 1.68
Phosphorylation of Munc-18/n-Sec1/rbSec1 by protein kinase C: its implication in regulating the interaction of Munc-18/n-Sec1/rbSec1 with syntaxin. J Biol Chem (1996) 1.65
Isolation of a yeast essential gene, COF1, that encodes a homologue of mammalian cofilin, a low-M(r) actin-binding and depolymerizing protein. Gene (1993) 1.64
Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest (1984) 1.63
Autoimmunity--a perspective. Annu Rev Immunol (1983) 1.62
The functional neuroanatomy of simple and complex sequential finger movements: a PET study. Brain (1998) 1.62
Tissue engineering of complex tooth structures on biodegradable polymer scaffolds. J Dent Res (2002) 1.61
NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment. Ann Intern Med (1984) 1.61
A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J Am Soc Nephrol (1999) 1.60
Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (1999) 1.60
Mechanism of allograft rejection in New Zealand mice. I. Cell synergy and its age-dependent loss. J Immunol (1973) 1.59
NIH conference. Systemic lupus erythematosus: evolving concepts. Ann Intern Med (1979) 1.59
Induction of immunologic tolerance in older New Zealand mice repopulated with young spleen, bone marrow, or thymus. J Exp Med (1970) 1.58
Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice. J Clin Invest (1981) 1.58
The natural history and immunopathology of outbred athymic (nude) mice. Clin Immunol Immunopathol (1975) 1.57
Comparative ultrasonographic and angiographic study of carotid arterial lesions in Takayasu's arteritis. Angiology (1997) 1.55
Identification of mycoplasma colonies by immunobinding. J Clin Microbiol (1986) 1.55
Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am J Med (1980) 1.53
Mycoplasma penetrans sp. nov., from the urogenital tract of patients with AIDS. Int J Syst Bacteriol (1992) 1.52
Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke (1976) 1.52
Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum (1979) 1.51
Long-term peritoneal dialysis is a risk factor of sclerosing encapsulating peritonitis for children. Perit Dial Int (2001) 1.50
Proposal of six new species in the genus Aureobacterium and transfer of Flavobacterium esteraromaticum Omelianski to the genus Aureobacterium as Aureobacterium esteraromaticum comb. nov. Int J Syst Bacteriol (1993) 1.50
Both primary motor cortex and supplementary motor area play an important role in complex finger movement. Brain (1993) 1.49
Evaluation of preserved urinary red blood cells by light microscopy. Clin Nephrol (1997) 1.48
Production and characterization of recombinant human neutrophil chemotactic factor. J Biochem (1989) 1.47